DocGo Inc.
DCGO · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.01 | -0.19 | -0.04 | 0.21 |
| FCF Yield | 0.07% | 20.63% | 2.79% | 2.83% |
| EV / EBITDA | -4.34 | -8.27 | -23.56 | -126.57 |
| Quality | ||||
| ROIC | -9.94% | -3.72% | -2.89% | -2.01% |
| Gross Margin | 25.60% | 31.61% | 32.12% | 33.52% |
| Cash Conversion Ratio | -0.06 | -2.53 | -0.87 | -1.69 |
| Growth | ||||
| Revenue 3-Year CAGR | -11.65% | -1.17% | 6.11% | 11.86% |
| Free Cash Flow Growth | -99.68% | 328.62% | -38.83% | -58.70% |
| Safety | ||||
| Net Debt / EBITDA | 2.06 | 3.24 | 1.71 | 10.14 |
| Interest Coverage | -190.92 | -39.40 | -32.84 | -13.80 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 122.26 | 120.82 | 139.20 | 125.32 |